ENVB 0.55 Enveric Biosciences, Inc.
| Range: | 0.361-2.92 | Vol Avg: | 1389534 | Last Div: | 0 | Changes: | 0.01 |
| Beta: | 0.5 | Cap: | 0.00B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Mon May 04 2015 | Empoloyees: | 7 | ||
| CUSIP: | 29405E208 | CIK: | 0000890821 | ISIN: | US29405E2081 | Country: | US |
| CEO: | Dr. Joseph Edward Tucker Ph.D. | Website: | https://www.enveric.com | ||||
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow